1017

Welcome to the October issue of The Ophthalmologist! Upfront’s topics include biomarkers for AMD and the perils of nerf guns. In My View sees Cynthia Matossian discuss the importance of diversity, and Berthold Seitz focuses on the merits of clinician-led research. In our “electrifying” Feature, D. Michael Ackermann shares his story on developing Oculeve – the nasal neurostimulator device for dry eye. In Practice sees Tony Realini discuss how to improve diagnosis of patients with normal tension glaucoma, and Elizabeth Shen and Jeremiah Tao focus on epiphora and how to manage patients with excessive tearing. In NextGen, Hao F. Zhang talks about developing new imaging technologies to assess retinal biological function, and in Profession, four dedicated Orbis volunteers share their experiences. Finally, we Sit Down With Sheraz Daya, Ophthalmologist and Medical Director of the Centre for Sight in the UK.

Articles featured in this issue

Business & Profession Other

When the World Changed Forever

09/28/2017 | Mark Hillen

The IBM PC changed computing forever. What might be ophthalmology's equivalent?

Subspecialties Retina

The Biomarker Breakdown

09/28/2017 | Ruth Steer

Could AMD be diagnosed through blood plasma analysis?

Subspecialties Retina

Detecting Dementia

09/28/2017 | Ruth Steer

Looking to the retina to find a biomarker for frontotemporal degeneration.

Subspecialties Retina

Screen the World

09/28/2017 | Ruth Steer

A global look at ROP screening.

Subspecialties Retina

The Chronic

09/28/2017 | Mark Hillen

There's chronic, and then there's chronic DME – and treatment outcomes differ accordingly.

Business & Profession Other

That's One in Your Eye

09/28/2017 | Mark Hillen

Nerf guns are fun. But not when they cause ocular trauma.

Subspecialties Retina

Treat the World

09/28/2017 | Ruth Steer

A global look at the rates of ROP and treatment.

Subspecialties Basic & Translational Research

Image of the Month

09/29/2017

Using seven different imaging modalities to visualize retinal organoids.

Business & Profession Professional Development

It’s Our Duty to ‘Do’ Diversity

09/29/2017 | Cynthia Matossian

A diverse workplace is worth having – so how do we go about achieving it?

Business & Profession Basic & Translational Research

Trust the Doctors to Deliver

09/29/2017 | Berthold Seitz

The benefits of a clinician-led approach to research.

Subspecialties Business and Innovation

It's Electrifying!

09/29/2017 | D. Ackermann

The behind-the-scenes story of Oculeve.

Subspecialties Glaucoma

Normal Tension Glaucoma: Are We Missing It?

09/29/2017 | Tony Realini

Prevention is better than cure – especially when there is no cure.

Business & Profession Cornea / Ocular Surface

Here Come the Waterworks!

09/29/2017 | Elizabeth Shen and Jeremiah Tao

Working up patients with excessive tearing.

Subspecialties Retina

Metabolism, Melanin and Multiple Modalities

09/29/2017 | Hao F. Zhang

How new imaging approaches are broadening our understanding of retinal biological function.

Business & Profession Cataract

Eyecare Sans Frontières – Part Deux

09/29/2017 | Ann-Marie Ablett

Meeting the volunteers who take to the skies to bring eyecare and education to those on the ground.

Subspecialties Cataract

On a Mission

09/29/2017 | Rob Walters

“The work that Orbis does is not about the ophthalmologists alone – it’s about the whole team.”

Business & Profession Cataract

From Trainee to Teacher

09/29/2017 | Andrew Choyce, Luu Tong

“Now I can work to help others in my position”

Subspecialties Professional Development

Ignore the “Gurus” and Follow the Evidence

09/29/2017 | Sheraz Daya

Sheraz Daya, Ophthalmologist and Medical Director of Centre for Sight in the UK

Subspecialties Retina

Peer-Reviewed Study Shows Optometrists and Ophthalmologists Frequently Miss Macular Degeneration

09/29/2017

A recent study published in JAMA Ophthalmology revealed how frequently optometrists and ophthalmologists fail to diagnose age-related macular degeneration.